Torm
TRMD
38.92
-0.13
-0.33%
Torm
US · TRMD
#2275 by market cap
Listed 1970
38.92
-0.13
-0.33%
Live - 5344 symbols - heartbeat 275s ago
· 2026-10-08 07:00
Pre-market
39.77
+2.18%
After-hours
39.25
+0.85%
Overnight
39.34
+1.08%
- Market cap
- 4.00B
- P/E (TTM)i
- 6.40
- P/Bi
- 1.57
- EPSi
- 2.85
- Div yieldi
- 6.22%
- 52W posi
- 89%
Reader sentiment
Are you bullish or bearish on TRMD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.58, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -14.09% YoY
Margins
- Gross margin
- 52.51%
- Operating margin
- 25.18%
- Net margin
- 21.30%
Key ratios & quality
- Enterprise valuei
- 4.84B
- Altman Z-Scorei
- 3.58
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 635.37M | 692.61M | 747.36M | 619.53M | 1.44B | 1.52B | 1.56B | 1.34B |
| Gross profit | 235.36M | 314.75M | 397.51M | 247.74M | 844.90M | 940.80M | 948.70M | 703.40M |
| Selling & admin expenses | 47.83M | 47.72M | 50.77M | 51.54M | 55.00M | 82.90M | 95.60M | 113.80M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 5.13M | 91.13M | 149.18M | 6.15M | 593.70M | 648.20M | 607.50M | 337.30M |
| Pretax profit | -33.22M | 166.81M | 89.53M | -40.75M | 556.70M | 652.00M | 609.50M | 295.20M |
| Tax | 1.56M | 784.00K | 1.42M | 1.34M | -5.90M | 4.00M | -2.00M | 9.20M |
| Net profit | -34.78M | 166.02M | 88.11M | -42.09M | 562.60M | 648.00M | 611.50M | 286.00M |
| Basic EPS | 0 | 2 | 1 | -1 | 7 | 8 | 7 | 3 |
| Diluted EPS | -0.48 | 2.24 | 1.19 | -0.54 | 6.80 | 7.48 | 6.36 | 2.85 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 329.10M | 315.20M | 342.60M | 352.60M | 402.00M | 662.80M |
| Gross profit | 165.40M | 158.10M | 183.60M | 196.20M | 227.80M | 452.30M |
| Selling & admin expenses | 25.90M | 24.50M | 29.20M | 29.20M | 23.00M | 24.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 72.90M | 69.20M | 97.70M | 97.60M | 137.30M | 355.10M |
| Pretax profit | 68.30M | 60.40M | 78.80M | 87.60M | 124.00M | 339.10M |
| Tax | 5.40M | 1.70M | 1.20M | 800.00K | 1.60M | 800.00K |
| Net profit | 62.90M | 58.70M | 77.60M | 86.80M | 122.40M | 338.30M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 3 |
| Diluted EPS | 0.62 | 0.58 | 0.77 | 0.87 | 1.18 | 3.25 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 269.30M | 215.91M | 243.66M | 363.32M | 739.70M | 691.20M | 615.30M | 531.90M |
| Cash & ST investments | 127.36M | 56.90M | 89.50M | 144.80M | 320.50M | 265.50M | 271.90M | 158.10M |
| Inventory | 39.40M | 34.84M | 22.46M | 48.81M | 72.00M | 61.70M | 68.40M | 66.50M |
| Total assets | 1.71B | 2.00B | 2.00B | 2.33B | 2.61B | 2.87B | 3.47B | 3.37B |
| Total current liabilities | 167.12M | 194.94M | 196.71M | 307.19M | 206.40M | 265.40M | 285.40M | 401.40M |
| Short-term debt | 94.42M | 99.03M | 102.86M | 208.95M | 117.10M | 172.70M | 165.30M | 288.80M |
| Long-term debt | 655.16M | 756.35M | 739.54M | 926.45M | 849.80M | 886.90M | 1.06B | 714.30M |
| Total liabilities | 867,189,000.00 | 996,194,000.00 | 981,174,000.00 | 1,278,819,000.00 | 1,110,500,000.00 | 1,204,100,000.00 | 1,394,800,000.00 | 1,164,400,000.00 |
| Total equity | 847.21M | 1.01B | 1.02B | 1.05B | 1.50B | 1.67B | 2.07B | 2.20B |
| Retained earnings | 752.11M | 919.96M | 939.25M | 899.47M | 1.30B | 1.38B | 1.47B | 1.79B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 694.20M | 682.80M | 517.70M | 531.90M | 575.50M | 846.60M |
| Cash & ST investments | 362.30M | 369.80M | 219.70M | 158.10M | 196.40M | 368.20M |
| Inventory | 72.50M | 69.50M | 65.00M | 66.50M | 82.50M | 111.80M |
| Total assets | 3.49B | 3.40B | 3.20B | 3.37B | 3.53B | 3.82B |
| Total current liabilities | 272.20M | 266.10M | 218.90M | 401.40M | 410.90M | 372.70M |
| Short-term debt | 161.40M | 156.20M | 121.90M | 288.80M | 286.70M | 237.00M |
| Long-term debt | 1.02B | 969.80M | 777.50M | 714.30M | 795.10M | 839.20M |
| Total liabilities | 1,344,500,000.00 | 1,289,400,000.00 | 1,045,000,000.00 | 1,164,400,000.00 | 1,259,300,000.00 | 1,272,900,000.00 |
| Total equity | 2.14B | 2.11B | 2.15B | 2.20B | 2.27B | 2.55B |
| Retained earnings | 1.54B | 1.60B | 1.69B | 1.79B | 1.92B | 2.26B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 70.74M | 171.09M | 235.80M | 47.95M | 502.00M | 805.00M | 826.80M | 498.90M |
| Depreciation & amortization | 114.48M | 110.12M | 121.92M | 130.85M | 139.00M | 149.30M | 192.00M | 214.50M |
| Free cash flow | -131.70M | -213.26M | 62.75M | -271.84M | 382.10M | 294.70M | 243.30M | 188.60M |
| Dividends paid | -- | 0 | -70.61M | 0 | -166.70M | -586.40M | -553.30M | -199.70M |
| Stock buybacks / issuance | -- | 0 | -1.35M | -- | -- | -- | -- | -- |
| Ending cash balance | 127.36M | 56.85M | 135.56M | 171.73M | 323.80M | 295.60M | 291.20M | 163.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 83.10M | 161.30M | 119.50M | 135.00M | 135.90M | 319.50M |
| Depreciation & amortization | 53.30M | 52.10M | 53.10M | 56.00M | 59.70M | 60.40M |
| Free cash flow | 55.10M | 133.20M | 83.00M | -82.70M | -48.40M | 245.40M |
| Dividends paid | 0 | -97.70M | -39.20M | -62.80M | -71.40M | -71.60M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 351.10M | 369.80M | 219.70M | 163.50M | 193.40M | 368.20M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -4.25 | 17.90 | 8.70 | -4.07 | 44.08 | 40.96 | 32.77 | 13.34 |
| ROA %i | -2.07 | 8.93 | 4.40 | -1.94 | 22.76 | 23.64 | 19.32 | 8.35 |
| ROIC %i | -0.51 | 11.71 | 7.20 | -0.47 | 25.73 | 26.75 | 21.48 | 10.50 |
| 5-year avg ROE %i | 0.31 | 3.03 | 1.29 | 3.72 | 12.47 | 21.52 | 24.49 | 25.42 |
| EBIT margin %i | 0.39 | 29.76 | 18.28 | -0.07 | 41.94 | 46.89 | 43.60 | 27.20 |
| FCF / sales %i | -- | -- | 8.40 | -- | 26.46 | 19.39 | 15.60 | 14.08 |
| Current ratioi | 1.61 | 1.11 | 1.24 | 1.18 | 3.58 | 2.60 | 2.16 | 1.33 |
| Quick ratioi | 1.30 | 0.77 | 0.78 | 0.76 | 2.83 | 1.83 | 1.69 | 0.96 |
| Debt / assetsi | 43.72 | 42.69 | 42.15 | 48.71 | 36.99 | 36.92 | 35.34 | 29.79 |
| LT debt / equityi | 77.33 | 75.06 | 72.68 | 88.05 | 56.60 | 53.30 | 51.16 | 32.43 |
| Interest coveragei | 0.07 | 5.24 | 2.90 | -0.01 | 12.43 | 11.71 | 9.67 | 5.27 |
| Revenue CAGR (3Y) %i | 5.54 | 0.61 | 4.39 | -0.84 | 27.73 | 26.71 | 36.02 | -2.46 |
| Net income CAGR (3Y) %i | -- | -- | 232.04 | -- | 50.22 | 94.50 | -- | -20.27 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 67.46 | -- | -20.97 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.17 | 15.86 | 13.17 | 13.34 | 15.62 | 26.84 |
| ROA %i | 13.33 | 9.59 | 8.35 | 8.35 | 9.82 | 17.32 |
| ROIC %i | 15.36 | 11.61 | 10.61 | 10.50 | 12.13 | 20.05 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 37.17 | 30.50 | 27.57 | 27.20 | 29.81 | 39.78 |
| FCF / sales %i | 24.48 | 17.13 | 19.00 | 14.08 | 6.03 | 11.21 |
| Current ratioi | 2.55 | 2.57 | 2.37 | 1.33 | 1.40 | 2.27 |
| Quick ratioi | 2.17 | 2.15 | 1.96 | 0.96 | 1.17 | 1.93 |
| Debt / assetsi | 33.91 | 33.15 | 28.13 | 29.79 | 30.63 | 28.15 |
| LT debt / equityi | 47.67 | 46.02 | 36.12 | 32.43 | 34.98 | 32.91 |
| Interest coveragei | 7.69 | 5.86 | 4.82 | 5.27 | 6.00 | 9.92 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Tanker Segment is the largest reported line at 99.40% of revenue, across 3 reported segments.
- The next-largest line, Marine Engineering segment, is a distant second at 1.04% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Tanker Segment99.40%
Marine Engineering segment1.04%
Quote time 2026-10-08 07:00:13 · For reference only, not investment advice and not tailored to your situation.